News from the College

Use the links below to read recent news and stories from the college.

  • Larner Graduates, Faculty Honored at UVM Commencement Weekend Ceremonies
    May 22, 2023
    Students, family, friends, faculty, and staff gathered May 20 and 21 to celebrate both the next generation of biomedical scientists and health professionals, as well as the exceptional academic achievements of several Larner College of Medicine faculty, during the University of Vermont’s Commencement Weekend.
  • Postdoctoral Research Showcased at UVM Event
    May 18, 2023
    Promising young scientists from colleges across the UVM campus gathered recently to celebrate the broad training experience, varied investigations, and collaborative community of UVM’s postdoctoral scholars. Organized by the UVM Postdoctoral Association, the event provided a chance for the scholars to present their research and network with peers.
  • Medical Students, Faculty, & Staff Recognized at Class of ’23 Honors Night
    May 17, 2023
    The Larner College of Medicine medical Class of 2023 Honors Night on May 15 featured recognition and awards for graduating medical students, faculty, and staff.
  • Teaching Academy Announces New Frymoyer Projects and Scholars
    May 15, 2023
    Three Larner College of Medicine faculty-led, group projects have been selected to receive 2023 Frymoyer Scholars funding. The three projects focus on supporting decisions on graduated responsibility in pathology residency; creating a two-week Ob/Gyn bootcamp curriculum focused on skill-building; and developing simulation-based educational modules for high-acuity, low-occurrence patient presentations in emergency departments at critical access hospitals.
  • Invention to Venture: Larner Creators Bring Medical Innovations to Marketplace
    May 11, 2023
    The Larner College of Medicine has been at the vanguard of technology transfer over the past decade, supporting patents and commercialization of faculty research, which has led to several successful startups. Recent examples of commercially successful innovations by Larner faculty include Prolocor, a startup company focused on developing a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.
  • Eat, Sleep, Console: Clinical Trial Identifies More Effective Way to Care for Opioid-Exposed Newborns
    May 2, 2023
    Research led by Leslie Young, M.D., demonstrates that the "Eat, Sleep, Console” care approach (ESC) for newborns exposed to opioids in the womb results in shorter hospital stays and decreased need for medication. National Institutes of Health funded the study. The findings are published in New England Journal of Medicine.
  • UVM Faculty-Founded THINKMD & Save the Children Expand Partnership
    April 27, 2023
    An expanded partnership between University of Vermont physician-founded THINKMD and global children’s health leader Save the Children aims to have a significant impact on the health and wellbeing of children in vulnerable communities across the globe.
  • Pre-Med Students Practice Skills, Gain Confidence, at Pathway to Pediatrics Event
    April 20, 2023
    Undergraduate students from groups under-represented in medicine often overlook pediatric medicine as a career choice. Larner medical students hosted an event to increase pediatrician diversity and support undergrads who feel apprehensive about medical school.
  • van der Vliet's Study Finds Potential New Treatment Target for Obesity-Associated Asthma
    April 19, 2023
    A new study in the American Journal of Physiology-Lung Cellular and Molecular Physiology by Albert van der Vliet, Ph.D., professor of pathology and laboratory medicine, and colleagues is honing in on why people with asthma often have worse symptoms if they are obese.
  • Seward Lab Lands Two-Year National Cancer Institute R21 Grant
    April 18, 2023
    UVM Cancer Center member David J. Seward, M.D., Ph.D., assistant professor of pathology and laboratory medicine, received a prestigious two-year National Cancer Institute R21 grant to investigate why lung cancers with a certain set of mutations demonstrate immunotherapy resistance.